We’ve made extraordinary progress in healthcare. However, outcomes depend on whether people can make treatment work in their ...

Biogen has entered into an agreement with TJ Biopharma (TJ Bio) to acquire exclusive rights to felzartamab in the Greater ...

Health technology firm myTomorrows and Rare Disease Research (RDR) have announced a US-based collaboration to improve patient ...

Sanofi’s Tzield (teplizumab) has received expanded approved from the US FDA, allowing it to be used for children aged one ...

AI is fundamentally changing the way marketing operates omnichannel journeys, enabling true next-best communication ...

AstraZeneca has reported positive high-level results from the phase 3 MIRANDA trial of tozorakimab, showing a statistically ...

Helus Pharma, a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic ...

Merck’s Enflonsia (clesrovimab) has been approved by the European Commission for the prevention of respiratory syncytial ...

Eli Lilly has agreed to acquire Kelonia Therapeutics in a deal valued at up to $7bn, as the company looks to expand its ...

Johnson & Johnson’s (J&J) Icotyde (icotrokinra) has been approved by the US FDA to treat moderate-to-severe plaque psoriasis (PsO) in both adults and paediatric patients. Icotyde, an interleukin-23 ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

Behaviour change is not primarily a matter of information or intention, but of habit, environment, identity and reward ...